Groowe Groowe / Newsroom / PFE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PFE News

Pfizer Inc.

Colorectal Cancer Advocates Urge Congress to Fund New Research

globenewswire.com
EXAS EXEL GSK GH ISRG MRK NTRA PFE

Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players

globenewswire.com
PFE JNJ AMGN ABBV SNY REGN MRK

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

accessnewswire.com
VALN PFE

Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised for Very Strong Growth: Expected to Reach $7.98 Billion by 2030

globenewswire.com
PFE JNJ MRK ABBV SNY BMY AZN NVS AMGN

Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players

globenewswire.com
AMGN BMY LLY JNJ PFE MRK ZWS

Clinical Nutrition for Diabetes Care Market Report 2026-2030 Featuring Profiles of Key Players - Pfizer, Bayer, Sanofi-Aventis, Abbott Labs, Roche and More

globenewswire.com
PFE SNY ABT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

accessnewswire.com
VALN PFE

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation

accessnewswire.com
VALN PFE

AI-powered Benefits Platform Origin Raises $30 Million Series A+, Bringing Total Funding to Over $50 Million to Tackle the Growing Inefficiency of Global Benefits Spend

businesswire.com
PFE CMCSA BP

Data Pipeline Failures Cost Enterprises $3 Million per Month, Fivetran Benchmark Finds

businesswire.com
FIVN PFE VZ